Tobias Hägglöv
Director of Finance/CFO at ELEKTA AB
Net worth: 75 511 $ as of 2024-03-30
Tobias Hägglöv active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ELEKTA AB | Director of Finance/CFO | 2022-01-31 | - |
Career history of Tobias Hägglöv
Former positions of Tobias Hägglöv
| Companies | Position | Start | End |
|---|---|---|---|
| RECIPHARM AB (PUBL) | Director of Finance/CFO | 2018-10-02 | 2020-12-31 |
LEAX Group AB
 LEAX Group AB Industrial MachineryProducer Manufacturing LEAX Group AB manufactures mechanical and electromechanical components and part systems. The firm offers business consultancy services, which include implementation of management, quality, and environmental systems and project management services. The company was founded in 1984 and is headquartered in Koping, Sweden. | Director of Finance/CFO | 2016-12-31 | 2017-12-31 |
| ELECTROLUX AB | Public Communications Contact | 2007-12-31 | 2011-12-31 |
| Corporate Officer/Principal | 2011-12-31 | 2016-12-31 | |
| Scandinavian Airlines System SAS | Investor Relations Contact | 2006-12-31 | 2007-12-31 |
Training of Tobias Hägglöv
| University of Stockholm | Graduate Degree |
| Royal Institute of Technology | Graduate Degree |
Statistics
International
| Sweden | 8 |
Operational
| Director of Finance/CFO | 3 |
| Graduate Degree | 2 |
| Public Communications Contact | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 3 |
| Consumer Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ELECTROLUX AB | Consumer Durables |
| ELEKTA AB | Health Technology |
| Private companies | 3 |
|---|---|
Recipharm AB
 Recipharm AB BiotechnologyHealth Technology Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden. | Health Technology |
LEAX Group AB
LEAX Group AB Industrial MachineryProducer Manufacturing LEAX Group AB manufactures mechanical and electromechanical components and part systems. The firm offers business consultancy services, which include implementation of management, quality, and environmental systems and project management services. The company was founded in 1984 and is headquartered in Koping, Sweden. | Producer Manufacturing |
| Scandinavian Airlines System SAS | Transportation |
- Stock Market
- Insiders
- Tobias Hägglöv
- Experience
